The project "RIBOLUTION – integrated platform for the identification and validation of innovative RNA-based biomarkers for personalized medicine" represents a research alliance supported by the Fraunhofer-Zukunftsstiftung (Fraunhofer Future Foundation).
New RNA biomarkers are identified and their diagnostic application validated for selected diseases using comprehensive, genome-spanning screening techniques. RIBOLUTION also includes so-called noncoding RNAs, which were recently discovered as a large reservoir of potentially valuable medical biomarkers.
Biomarkers are being sought that function as diagnostic indicators to reveal diseases or predict their course or response to therapy. In addition, the process of biomarker screening will be optimized and perfected by RIBOLUTION with the aid of technical innovations.